This July 18, 2020, file photo, shows the AstraZeneca offices in Cambridge, England. LONDON, UNITED KINGDOM -- British pharma giant AstraZeneca said on Monday trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among elderly, as well as younger participants.
The positive news emerged in data on the safety and immune responses of participants in the phase II stage of the trial Oxford has submitted for peer review in a medical journal. Oxford and AstraZeneca have been trialing their potential vaccine for months in various countries around the world.
Never been able to make a corona virus vaccine in history yet they think they can now pump one or after 9 months.
Sure it has
ain't taking no vaccine until at least a year after approval. That's my personal choice.
Pity it’s not available in Canada. Thanks Justin.
Why are they called vaccines when their results are only 'encouraging'?
You mean the company that had a volunteer die in their trials? Sounds encouraging....
'Encouraging'?! Ah! 😂🤣 Next!
At this late stage they use the word “encouraging”. Bad very bad news
Would they tell us otherwise?
Proverbial and ONLY question is WHEN ?
Keep in mind... 'Prevention of infection is not a criterion for success for any of these vaccines.' This vaccine is looking at reducing the severity of the SYMPTOMS. This is a very important piece of information that we all must understand! FactsMatter